Skip to main content

Notice for methoxsalen (Teruma BCT Australia Pty Ltd)

Active ingredients
methoxsalen
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution
Indication
For the treatment of Graft versus Host Disease (GVHD) following allogeneic Hematopoietic Stem Cell (HSC) transplantation.
Therapeutic area
Immunology

Help us improve the Therapeutic Goods Administration site